INBONE Technologies Inc.
This article was originally published in Start Up
Executive Summary
Suddenly, small bone reconstruction, once a fragmented and un-noticed segment of orthopedics, is gaining steam, with a number of large-company acquisitions and the emergence of new kinds of consolidators. Now a new player, INBONE Technologies, is hedging its bet on an innovative total ankle replacement device with a longer product life.
You may also be interested in...
Could Pharma's Appetite Spill Over To Devices?
Mergers and acquisitions, once the tried-and-true method of exits for device investors, are now being dominated by Big Pharma. But can this appetite benefit device investors?
Start-Up Previews (11/2007)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Antibody Start-Ups," features profiles of 4-Antibody, Anaptys Biosciences and f-star. Plus these Start-Ups Across Health Care: Actuality Medical, INBONE Technologies, Interrad Medical and Tethys BioScience.
Start-Up Previews (11/2007)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Antibody Start-Ups," features profiles of 4-Antibody, Anaptys Biosciences and f-star. Plus these Start-Ups Across Health Care: Actuality Medical, INBONE Technologies, Interrad Medical and Tethys BioScience.